JP2019512262A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019512262A5 JP2019512262A5 JP2018560245A JP2018560245A JP2019512262A5 JP 2019512262 A5 JP2019512262 A5 JP 2019512262A5 JP 2018560245 A JP2018560245 A JP 2018560245A JP 2018560245 A JP2018560245 A JP 2018560245A JP 2019512262 A5 JP2019512262 A5 JP 2019512262A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- acid sequence
- amino acid
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16154507.4 | 2016-02-05 | ||
| EP16154507.4A EP3202788A1 (en) | 2016-02-05 | 2016-02-05 | Endosialin-binding antibody |
| PCT/EP2017/052399 WO2017134234A1 (en) | 2016-02-05 | 2017-02-03 | Endosialin-binding antibody |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019512262A JP2019512262A (ja) | 2019-05-16 |
| JP2019512262A5 true JP2019512262A5 (enExample) | 2020-03-12 |
| JP7094893B2 JP7094893B2 (ja) | 2022-07-04 |
Family
ID=55310735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560245A Expired - Fee Related JP7094893B2 (ja) | 2016-02-05 | 2017-02-03 | エンドシアリン結合抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11318210B2 (enExample) |
| EP (2) | EP3202788A1 (enExample) |
| JP (1) | JP7094893B2 (enExample) |
| AU (1) | AU2017216284A1 (enExample) |
| CA (1) | CA3012270A1 (enExample) |
| WO (1) | WO2017134234A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3773739A1 (en) * | 2018-04-12 | 2021-02-17 | MediaPharma S.r.l. | Lgals3bp antibody-drug-conjugate and its use for the treatment of cancer |
| WO2020099235A1 (en) * | 2018-11-12 | 2020-05-22 | Mediapharma S.R.L. | Bispecific antibodies directed against human 90k and either endosialin or her3 |
| US20220088231A1 (en) | 2018-12-03 | 2022-03-24 | Fusion Pharmaceuticals Inc. | Radioimmunoconjugates and dna damage and repair inhibitor combination therapy |
| US12297276B2 (en) | 2019-05-31 | 2025-05-13 | Ludwig Institute For Cancer Research Ltd | Anti-TEM1 antibodies and antigen-binding portions thereof |
| MX2022006881A (es) | 2019-12-06 | 2022-07-11 | Ablynx Nv | Polipeptidos que comprenden dominios variables unicos de inmunoglobulina dirigidos a tnf alfa y ox40l. |
| WO2021207086A1 (en) * | 2020-04-06 | 2021-10-14 | Fusion Pharmaceuticals Inc. | Tem-1-targeted radioimmunoconjugates and uses thereof |
| JP7842101B2 (ja) | 2020-12-18 | 2026-04-07 | アブリンクス エン．ヴェー． | ＩＬ－６およびＴＮＦ－αを標的化する免疫グロブリン単一可変ドメインを含むポリペプチド |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| AU631545B2 (en) | 1988-04-15 | 1992-12-03 | Protein Design Labs, Inc. | Il-2 receptor-specific chimeric antibodies |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| WO2006017759A2 (en) * | 2004-08-05 | 2006-02-16 | Kirin Brewery Co., Ltd. | Tumor endothelial marker-1 (tem1) binding antibodies and uses thereof |
| ITRM20090081A1 (it) | 2009-02-25 | 2010-08-26 | Stefano Iacobelli | Uso di inibitori della proteina 90k per la preparazione di un medicamento per la cura o prevenzione dei tumori. |
| WO2010118203A2 (en) * | 2009-04-09 | 2010-10-14 | Morphotek, Inc. | Endosialin binding molecules |
| KR20140033152A (ko) * | 2011-06-20 | 2014-03-17 | 교와 핫꼬 기린 가부시키가이샤 | 항erbB3 항체 |
| JP6285414B2 (ja) * | 2012-03-30 | 2018-02-28 | モルフォテック， インコーポレイテッド | Ｔｅｍ−１診断用抗体 |
-
2016
- 2016-02-05 EP EP16154507.4A patent/EP3202788A1/en not_active Ceased
-
2017
- 2017-02-03 AU AU2017216284A patent/AU2017216284A1/en not_active Abandoned
- 2017-02-03 US US16/075,849 patent/US11318210B2/en active Active
- 2017-02-03 CA CA3012270A patent/CA3012270A1/en active Pending
- 2017-02-03 JP JP2018560245A patent/JP7094893B2/ja not_active Expired - Fee Related
- 2017-02-03 WO PCT/EP2017/052399 patent/WO2017134234A1/en not_active Ceased
- 2017-02-03 EP EP17703724.9A patent/EP3411405A1/en not_active Withdrawn
-
2022
- 2022-03-29 US US17/707,838 patent/US20220218836A1/en not_active Abandoned